About Novus Diagnostics
Novus Diagnostics is a company based in Dublin (Ireland) founded in 2020. Novus Diagnostics has raised $7.66 million across 5 funding rounds from investors including Trinity Biotech, Enterprise Ireland and European Union. Novus Diagnostics offers products and services including SepTec™ Technology and Diagnostic Platform. Novus Diagnostics operates in a competitive market with competitors including The Fertility Partners, George Institute, HD, Arialys and Genertec Universal Medical Group, among others.
- Headquarter Dublin, Ireland
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Novus Diagnostics Ltd
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$7.66 M (USD)
in 5 rounds
-
Latest Funding Round
$2.5 M (USD), Series A
Oct 25, 2024
-
Investors
Trinity Biotech
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Novus Diagnostics
Novus Diagnostics offers a comprehensive portfolio of products and services, including SepTec™ Technology and Diagnostic Platform.
Platform for rapid sepsis detection using sensors and algorithms.
System that provides bedside results for infectious disease classification.
Funding Insights of Novus Diagnostics
Novus Diagnostics has successfully raised a total of $7.66M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $2.5 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Novus Diagnostics
Novus Diagnostics has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Trinity Biotech, Enterprise Ireland and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Support is provided to Irish manufacturing and service sector businesses.
|
Locked | Locked | Locked |
Investor details for Novus Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Novus Diagnostics
Investment portfolio details for Novus Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Novus Diagnostics
Detailed financials for Novus Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Novus Diagnostics Comparisons
Peer comparison for Novus Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Novus Diagnostics
Novus Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as The Fertility Partners, George Institute, HD, Arialys and Genertec Universal Medical Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Business consulting services for fertility practices are provided.
|
|
| Locked | Locked | Locked |
Medical research is conducted by the institute in health fields.
|
|
| Locked | Locked | Locked |
Medical information services are provided in the healthcare sector.
|
|
| Locked | Locked | Locked |
Precision medicines for autoimmune neuropsychiatric diseases are developed.
|
|
| Locked | Locked | Locked |
Provider of medical information solutions
|
Detailed competitors of Novus Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Novus Diagnostics
Complete news archive for Novus Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Novus Diagnostics
Novus Diagnostics was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Novus Diagnostics is headquartered in Dublin, Ireland.
Keith ONeill is the current CEO of Novus Diagnostics.
Novus Diagnostics is a funded company, having raised a total of $7.66M across 5 funding rounds to date.
Novus Diagnostics, backed by 13802179.014 from Trinity Biotech, EIC Fund, Enterprise Ireland, European Union, Grimpeur Holdings, focuses on providing healthcare solutions, services for healthcare providers, and medical information providers. Provider of diagnostic information services for clinicians. Driving innovation, growth, and excellence in its industry sectors.
Novus Diagnostics's top competitors include George Institute, The Fertility Partners and HD.
Novus Diagnostics offers SepTec™ Technology and Diagnostic Platform.
Novus Diagnostics has 5 investors. Key investors include Trinity Biotech, Enterprise Ireland, European Union, EIC Fund, and Grimpeur Holdings.